Sotagliflozin, a dual SGLT1/2 inhibitor, increased hemoglobin levels in patients with type 2 diabetes and chronic kidney ...

Crohn’s disease may be a lifelong condition, but today, there are an abundance of effective treatments that can help bring relief to your symptoms and reduce your risk of experiencing more serious ...

A new study published in the journal of BMC Nephrology showed that the effectiveness of roxadustat is comparable at varying ...

The 2023 AABB guidelines overall favor a restrictive transfusion strategy, recommending RBC transfusion for hemoglobin <7 ...

The world of health devices and therapy is evolving faster than ever and 2024 is shaping up to be a groundbreaking year From wearable tech that monitors your vitals in real time to cutting-edge therap ...

Kentucky medical cannabis practitioners could begin writing certifications for medical cannabis treatment on Dec. 1. Local ...

Following a phase 1b trial, the potent and selective dual inhibitor of IRAK1 and IRAK4 received fast track designation for the treatment of patients with lower-risk myelodysplastic syndrome.

“As a potent and targeted c-Kit inhibitor, I believe briquilimab has the potential to overcome the safety issues that have limited development of other c-Kit inhibiting agents and, in turn, serve as ...

Do you feel bloated, fatigued or have frequent digestive discomfort? Small Intestinal Bacterial Overgrowth (SIBO) affects a ...

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced that the U.S. Food and Drug Administration (FDA) has ...

The S1 heart sound is two of your heart valves closing. It's the first sound doctors can hear with a stethoscope. Learn what ...

Bridgewater Associates LP cut its position in Amgen Inc. (NASDAQ:AMGN – Free Report) by 61.4% during the third quarter, ...